Saturday, July 11, 2026

pharma · Hypovolemia · Pruritus, Chronic Kidney Diseases

Fresenius Kabi Australia

Fresenius Kabi Australia clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Mount Kuring-Gai, AU HQ
150 Employees
TGA registrant Type
Company details
Status
Public
HQ
Mount Kuring-Gai, AU
Employees
150
Programs
5
Drugs
6
Patents
0
Intelligence · Clinical Programs

Fresenius Kabi Australia projects

3 ClinicalTrials.gov programs sponsored by Fresenius Kabi Australia.

Fresenius Kabi Australia has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Comparison of Prefilled syringe and Autoinjector presentations of FYB202

    Fresenius Kabi Australia Pty Limited

    Chronic inflammatory diseases

    phase 1 other active

    1 trial
  2. MSB11455

    Fresenius Kabi Australia Pty Limited

    Healthy

    phase 1 small molecule completed

    1 trial
  3. MSB11456

    Fresenius Kabi Australia Pty Limited

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Fresenius Kabi Australia have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.